Ivermectin Pour-on Solution for Cattle 5 mg/ml Virbac

Summary of Product characteristics

                                Revised: April 2015
AN : 01613/2014
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ivermectin pour-on solution for cattle 5 mg/ml Virbac
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance
Ivermectin
5.0 mg/ml
Excipient(s):
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Pour-on solution.
Clear, colourless to pale yellow solution.
4. CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Ivermectin pour-on solution for cattle 5 mg/ml Virbac is indicated for
the
treatment of gastro-intestinal nematodes, lungworms, warbles,
chorioptic and
sarcoptic mange mites, sucking and biting lice of beef and
non-lactating dairy
cattle.
Gastro-intestinal roundworms
Ostertagia ostertagi
(L4, adults and inhibited stages)
Haemonchus placei
(L4, adults)
Trichostrongylus axei
(L4, adults)
Trichostrongylus colubriformis
(L4, adults)
Cooperia spp.
(adults)
Cooperia punctata
(adults)
Cooperia oncophora
(adults)
Oesophagostomum radiatum
(L4, adults)
Strongyloides papillosus
(adults)
Trichuris spp.
(adults)
Lungworms (adults and 4th-stage larvae)
Dictyocaulus viviparus
Warbles (parasitic stages)
Hypoderma bovis
Hypoderma lineatum
Mites
Sarcoptes scabiei var. bovis
Chorioptes bovis
Lice
- Sucking lice
Linognathus vituli
Haematopinus eurysternus
Revised: April 2015
AN : 01613/2014
Page 2 of 7
- Biting lice
Damalinia bovis
The product, at the recommended use level of 500 μg/kg of ivermectin,
has a
persistent activity on:
Dictyocaulus viviparus:
for up to 28 days
Ostertagia spp.:
for up to 21 days
Oesophagostomum radiatum:
for up to 21 days
Cooperia spp.:
for up to 14 days
Trichostrongylus axei:
for up to 14 days.
The product helps in the control of the mange mite Chorioptes bovis
but
complete elimination may not occur.
The product has also a persistent activity on the horn fly (Haematobia
irritans)
for 28 days; partial efficacy may last for up to 35 days post
application.
Occasionally, variable activity may be observe
                                
                                Read the complete document